Fund.TBD
Swing Trader, Technical/Fundamental Analysis
Hinge Health is the best name in healthcare information, the hottest industry of the past quarter. Strong new contracts with health plans have boosted its margins significantly, while good cash flow and conservative leverage add a margin of safety. x.comÂ
Hinge Health is building a constructive cup-and-handle base near its highs while its fundamentals keep moving the right way. Estimates call for 2028 EPS of $4.30 and revenue of $1.5B, nearly double 2026 levels. x.comÂ
Hinge Health's revenue growth and cash generation strengthen its case as a leading non-tech IPO near all-time highs. The attached portfolio-stock analysis projects 46% revenue growth in 2026 and puts Q2 free cash flow at about $100 million, roughly three times the year-earlier level. It lists further revenue and margin expansion as potential catalysts. x.com x.comÂ
Hinge Health, Navan, Pattern Group and Medline are young IPO leaders breaking out of their IPO bases with strong institutional accumulation while trading above their IPO VWAP. Today's young IPOs showing that pattern often become tomorrow's market leaders. x.comÂ
Healthcare's recovery is still in early innings because rotation keeps flowing in. Investors are dumping software for hardware, and those who see hardware as saturated are moving into healthcare as a defensive, long-undervalued sector; the richer hardware gets, the stronger that pull. Oscar Health hit its short-term target early and can reach $40 if this quarter resembles Q1. UnitedHealth, near $410, can aim for $425 to $450 on another beat and raise in Q2. x.comÂ
Stryker's rare double miss looks like quarterly noise, since full-year 2026 guidance is unchanged. Healthcare stocks are widely hated after five years of broken charts from the COVID boom-bust, but fundamentals say otherwise. They are the ultimate safety stocks, and the time to buy them is when no one wants them. x.comÂ
UnitedHealth should outperform through year-end on midterm-year seasonality and as a defensive leader if markets weaken. Over the last 20 years, healthcare has generally done well from July through December in midterm years, and if the S&P 500 rolls into a bear market, investors should rotate into defensives led by UNH. The bull case also rests on AI and GLP-1 use lowering the medical cost ratio and institutions returning to healthcare. The war has made everything more volatile. x.comÂ